Spectrum Vascular , a provider of vascular access and medication management products designed to reduce health care-acquired infections, is pleased to announce the appointment of Ken Miller as Chief Executive Officer and Doug Shook as Chief Commercial Officer. These strategic leadership additions mark a pivotal step in advancing Spectrum’s mission to deliver improved patient outcomes and scale its impact across key markets, building upon recent momentum following a strategic investment by SK Capital in late March.
“Ken and Doug are proven leaders who share our values and vision,” said Jon Borell, Managing Director at SK Capital. “The Spectrum Vascular Board of Directors, as well as the SK Capital and Event Capital Strategies teams, are thrilled to partner with them as we position Spectrum for its next chapter.”
Health Technology Insights: Bruker Enhances IR Biotyper with NGS for HAI Tracing
Ken Miller Appointed as Chief Executive Officer
A seasoned executive with more than 35 years of leadership experience in the medical device industry, Mr. Miller brings a proven ability to drive commercial and operational excellence across both growth-stage and established healthcare organizations. He joins Spectrum from KORU Medical Systems where he served as Chief Commercial Officer since 2023. Prior to KORU, Mr. Miller held executive leadership positions at Nasco Healthcare, Becton Dickinson & Company and Novo Nordisk, where he led high-performing teams, expanded market presence and delivered consistent revenue growth.
Health Technology Insights: nVoq Welcomes Michael Quinn as Vice President of Strategic Business Development
“I am honored to join Spectrum Vascular at such a critical stage in its journey,” said Mr. Miller. “The Company’s commitment to patient care and innovation, combined with the recent support from SK Capital, create a strong foundation for growth. I look forward to working with the Spectrum team to elevate our impact and expand access to Spectrum’s critical care technologies.”
Doug Shook Appointed Chief Commercial Officer
Mr. Shook brings more than two decades of commercial leadership experience in the medical technology space to his new role, with deep expertise in driving go-to-market strategies and scaling customer engagement. He joins Spectrum from ICU Medical, where he served as the Global Business Unit Leader for Vascular Access and led commercial operations across the vascular access portfolios. Prior to ICU Medical, Mr. Shook held commercial leadership roles at Smiths Medical and Access Scientific, manufacturers of premium vascular access devices for the acute and ambulatory care markets.
“I’m excited to join Spectrum at a time of strong momentum and opportunity,” said Mr. Shook. “With a differentiated portfolio and clear focus on infection prevention, we’re well-positioned to expand our market presence and deepen our impact across healthcare systems.”
Health Technology Insights: Credex Launches Staffing for Credentialing and Enrollment
To participate in our interviews, please write to our HealthTech Media Room at sudipto@intentamplify.com
Source – PR Newswire
